This site is intended for healthcare professionals only
LoginRegister
CiplaCipla Secures CDSCO Panel Nod to Manufacture Amantadine Oral Solution with Trial Waiver
Delhi HC Bars Dr Reddys from Selling Olymviq Over Similarity with Novo Nordisks OzempicLiv-333 Violates Liv.52 Trademark, Delhi HC Slaps Rs 20 Lakh Damages on Rajasthan Aushdhalaya for...
Cipla Recalls Cancer Drug Nilotinib in US Over Manufacturing IssueGranules recalls over 33000 bottles BP medication in US
Accused ArrestedArrest made in Hyderabad over fake Sun Pharma anti-epileptic medicine
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon appoints Ekta Agarwal as Interim Company Secretary, Compliance Officer
IIM Ahmedabad, Novo Nordisk India collaborate for obesity care ecosystemNovo Nordisk India, IIM Ahmedabad collaborate for obesity care ecosystem
Eli Lilly to Acquire Ajax Therapeutics in USD 2.3 Billion Cancer Drug PushEli Lilly gets USFDA okay for updated Kisunla label with new dosing in early symptomatic Alzheimer's...
Shilpa Medicare Enters US Transdermal Market, Files First ANDA for Rotigotine PatchShilpa Medicare Unit VI Bengaluru facility receives Saudi Arabian GMP certification
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsEmcure Pharma Ahmedabad oncology facility concludes USFDA inspection with no observations
Alembic buys UTI-focused Utility Therapeutics in USD 12 million dealMerck to buy Verona Pharma for USD 10 billion
CDSCO Panel Recommends Phase IV Trial for Acne FDC Gel by Precise BiopharmaCDSCO Panel Recommends Phase IV Trial for Acne FDC Gel by Precise Biopharma
GlaxoSmithKline Pharma names Vishwanath Swarup as Commercial Head - General MedicinesGlaxoSmithKline Pharma names Vishwanath Swarup as Commercial Head - General Medicines
X